VAPT Testing for Healthcare in India: How to Scope It Without Missing Patient Risk

A hospital group in Pune is preparing to onboard a new diagnostics partner. The partner’s security questionnaire asks for recent vulnerability assessment and penetration testing evidence, but the IT team has only a generic network scan from last year. Meanwhile, the hospital’s patient portal, lab information system, imaging archive and remote-access route for doctors all sit on different platforms managed by different vendors. This is the point where VAPT testing needs to be planned around patient care and data flows, not treated as one blanket scan across the IT estate.

For healthcare providers, diagnostic chains, health-tech platforms, pharmacies and medical device operators in India, VAPT testing should validate exploitable weaknesses across patient-facing applications, clinical systems, connected devices, cloud services and internal networks. The goal is to understand whether an attacker could reach protected health information, disrupt clinical operations or move from a low-value system into a high-value one.

Why healthcare needs a different testing approach

Healthcare environments rarely look like a normal corporate IT network. A single hospital may run a patient portal, appointment booking system, laboratory information system, radiology workflow, electronic medical record platform, billing application, staff Wi-Fi, guest Wi-Fi, building-management systems and connected diagnostic equipment. Many of these systems are procured, hosted or maintained by different vendors.

That fragmentation creates a specific risk: a weak link in one system can become a route into another. A compromised staff laptop, an exposed remote-access service, an outdated imaging workstation or a poorly configured cloud storage bucket may expose far more than its immediate function. In a healthcare setting, the impact is not limited to data theft; it can affect appointment continuity, diagnostic turnaround, clinical decision-making and patient safety.

A useful pen testing programme therefore begins with a data-flow map. It identifies where patient identity, clinical records, prescriptions, reports, insurance details and payment information are created, stored, transmitted and accessed. Only after that map exists can a testing team decide which systems deserve deep manual testing and which need broader assessment coverage.

What should be in scope?

The most important question is not “which servers should we scan?” It is “which systems, if compromised, would expose patient data or disrupt care?”

A practical healthcare scope should include patient-facing web and mobile applications, appointment and teleconsultation platforms, patient portals, laboratory and radiology interfaces, billing and insurance workflows, APIs used by partners, cloud-hosted applications, remote-access services and administrative systems. It should also consider connected medical and diagnostic devices where they are technically testable and where testing will not interfere with patient care.

Scope must distinguish between production and non-production environments. Testing a patient portal in staging is useful, but it may not reveal risks created by live integrations, real identity providers, production cloud permissions or operational vendor connections. If production testing is restricted for safety reasons, the test environment should be documented, and the limitations should be stated clearly in the final report.

Clinical safety comes before testing depth

Healthcare testing needs stricter rules of engagement than most industries. A tester cannot treat every system as fair game simply because it is connected to the network.

Before work begins, the provider and testing team should agree on:

• Systems that are strictly out of bounds because of patient-safety or operational criticality.
• Test windows that avoid peak clinical hours, critical diagnostics or system-change periods.
• Approved test accounts and realistic user roles, such as patient, front-desk staff, doctor, lab technician and administrator.
• Emergency contacts, escalation paths and a documented process to stop testing immediately.
• Rules for handling any patient data encountered during testing, including secure deletion or redaction after the engagement.

This is not bureaucratic caution. In most healthcare engagements, the first thing a competent tester asks for is a clear list of systems that must not be interrupted. A vulnerability that can be tested safely in a controlled environment should not be exploited in a way that could affect a live clinical workflow.

VA and PT answer different questions

Healthcare teams often receive a vulnerability assessment and assume they have completed penetration testing. The two activities overlap, but they do not provide the same assurance.

Both are necessary. A hospital with hundreds of endpoints needs regular vulnerability assessment to keep patching and configuration drift under control. But a patient portal, telemedicine platform or lab-report API also needs manual testing, because the most damaging issues often involve authorisation, session handling, business logic or integration trust—not a missing patch alone.

The findings that matter most in healthcare

In practice, healthcare testers often find issues that a standard scan does not surface. One common category is broken access control: a patient may be able to view another patient’s report by changing an identifier in a URL or API request. Another is excessive privilege, where a front-desk user can access clinical notes or a laboratory technician can alter report metadata without appropriate approval.

Integration weaknesses are also frequent. A diagnostic centre may exchange reports with a hospital through an API that trusts the caller too readily, or a health-tech application may store reports in cloud storage with permissions broader than necessary. Remote access is another recurring concern, especially where doctors, vendors and field staff use different access methods without consistent multi-factor authentication or device controls.

Connected devices deserve careful treatment. Many medical and diagnostic devices run older operating systems, use embedded software or depend on vendor-controlled update cycles. They may not be suitable for intrusive testing, but their network exposure, default credentials, management interfaces and segmentation should still be reviewed. The objective is to determine whether a device can be reached from a broader network segment and whether compromise could affect clinical systems.

What auditors and enterprise partners will ask

Healthcare providers in India increasingly face security questionnaires from insurers, corporate clients, hospital groups, diagnostic partners and health-tech platforms. They may also need to demonstrate alignment with the DPDP Act, ISO 27001, SOC 2 expectations or customer-specific contractual controls. The exact obligation depends on the organisation’s role, data processed and contractual commitments, so the current requirements should be checked against the applicable regulator, standard or agreement.

A typical reviewer will not only ask whether a VAPT report exists. They will ask whether the scope covered patient-facing and clinical systems, whether testing was independent, whether findings were remediated within defined timelines, and whether retesting confirmed closure. They may ask for an executive summary, evidence of critical and high-risk remediation, and a statement of any exceptions or accepted risks.

This is where many organisations fall short. They can produce a report, but they cannot show a findings register, remediation ownership, closure evidence or a repeatable testing cadence. A strong programme treats the report as the beginning of risk management, not the end of a project.

A simple prioritisation framework

Healthcare teams can use three questions to decide where to invest first.

First, does the system directly handle patient identity, clinical records, prescriptions, diagnostic reports, insurance information or payments? These systems should receive deeper, role-based manual testing.

Second, can the system be reached from the internet, a partner network, remote access or a less-trusted internal segment? Exposure increases the urgency of testing, particularly for remote-access gateways, APIs and cloud-hosted services.

Third, has the system changed recently? A new patient app, laboratory integration, cloud migration, vendor replacement or teleconsultation feature can introduce risk even if the wider environment was tested recently. Change-driven testing is often more useful than waiting for the next annual cycle.

A sensible starting sequence is to test patient-facing applications and APIs first, then privileged administrative and remote-access paths, then clinical integrations and cloud configuration, and finally connected devices and network segmentation where feasible. This sequence reflects both attacker interest and patient impact.

Common mistakes to avoid

One frequent mistake is assuming that a vendor-managed application is the vendor’s responsibility alone. The hospital or health-tech company may still own identity configuration, user provisioning, data-sharing permissions, network exposure and contractual oversight. Shared responsibility does not mean no responsibility.

Another is focusing only on the patient portal. It is visible and important, but attackers often prefer quieter routes: an exposed file-transfer service, a weak remote-access setup, an over-permissive cloud bucket or an internal system with reused credentials.

A third mistake is treating medical devices as untouchable. They may require careful handling, but excluding them completely can leave a major blind spot. Even when intrusive testing is inappropriate, reviewing their network placement, management access, patch status and vendor support arrangements provides meaningful assurance.

Finally, do not judge a provider by the thickness of its report. A useful healthcare VAPT report clearly separates validated exploitation from theoretical findings, explains clinical and data impact, identifies remediation owners and provides retest evidence. A report dominated by low-value scanner output may create paperwork without improving security.

What a good report should enable

A good report should allow the chief information security officer, IT operations team, clinical leadership and compliance function to act without confusion. Leadership should see the overall risk position and the systems that require urgent attention. Security and IT teams should see validated findings, affected assets, severity, evidence and practical remediation advice. Compliance and audit teams should see scope, methodology, limitations, remediation status and retest outcomes.

It should also make vendor accountability clear. Where an issue sits in a third-party application, the report should identify the responsible party and the evidence needed to close it. This prevents the common situation where the hospital, software vendor and cloud provider each assume someone else will fix the issue.

How often should healthcare organisations test?

There is no single frequency that suits every healthcare organisation. Critical and internet-facing systems generally need more frequent attention than isolated internal systems, and major changes should trigger focused testing. A patient portal, telehealth platform, laboratory integration or cloud-hosted electronic medical record environment should be tested after significant releases or configuration changes, not only on a fixed annual schedule.

For a multi-location diagnostics chain or hospital group, a rolling programme often works better than one large annual exercise. Testing one business unit, application cluster or integration layer at a time keeps the effort manageable while ensuring that high-risk systems are revisited regularly.

IBN Technologies provides VAPT testing for healthcare providers and health-tech companies in India, including application, API, cloud, network and connected-device security testing, with remediation support and retesting.

Contact Us
IBN Technologies
Phone: +91 20 6768 0404
Email: sales@ibntech.com